Quick Answer
Citius Pharmaceuticals, Inc. reported Total Assets of $130.94 million for fiscal year 2025.
Citius Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $130.94M | +12.2% |
| 2024 | $116.65M | +12.6% |
| 2023 | $103.61M | -9.1% |
| 2022 | $114.00M | -20.0% |
| 2021 | $142.43M | +225.4% |
| 2020 | $43.77M | +19.1% |
| 2019 | $36.75M | +18.3% |
| 2018 | $31.05M | +27.2% |
| 2017 | $24.42M | +11.2% |
| 2016 | $21.95M | +2860.1% |
| 2015 | $741.5K | -52.4% |
| 2014 | $1.56M | — |
| 2013 | $0.00 | -100.0% |
| 2012 | $135.00 | -36.3% |
| 2011 | $212.00 | -91.5% |
| 2010 | $2.5K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $140.39M | +16.3% | +7.2% |
| September 30, 2025 | $130.94M | +12.2% | +2.6% |
| June 30, 2025 | $127.68M | +31.5% | +5.1% |
| March 31, 2025 | $121.48M | +33.9% | +0.6% |
| December 31, 2024 | $120.70M | +23.9% | +3.5% |
| September 30, 2024 | $116.65M | +12.6% | +20.1% |
| June 30, 2024 | $97.09M | -12.1% | +7.0% |
| March 31, 2024 | $90.71M | -13.0% | -6.9% |
- Citius Pharmaceuticals, Inc. showed an increase of +12.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Citius Pharmaceuticals, Inc.’s total assets has grown by 5237421.0% (from $2.5 thousand to $130.94 million).
- The most recent figure is from Citius Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: